Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. PRETI RA; ZAHOS KM; JENNIS AA; MURAWSKI J; NADASI S; DORIA L; ISAACS RE; BROCHSTEIN JA; PECORA AL
   EFFECT OF INTERFACE OFFSET (I/O) ADJUSTMENT ON COLLECTION EFFICIENCY USING THE FENWAL CS3000 PLUS BLOOD-CELL SEPARATOR FOR PERIPHERAL-BLOODPROGENITOR-CELL COLLECTION/
   Journal of hematotherapy
   
   R.A. Preti et al., "EFFECT OF INTERFACE OFFSET (I/O) ADJUSTMENT ON COLLECTION EFFICIENCY USING THE FENWAL CS3000 PLUS BLOOD-CELL SEPARATOR FOR PERIPHERAL-BLOODPROGENITOR-CELL COLLECTION/", Journal of hematotherapy, 7(1), 1998, pp. 53-61
2. SOSMAN JA; ARONSON FR; SZNOL M; ATKINS MB; DUTCHER JP; WEISS GR; ISAACS RE; MARGOLIN KA; FISHER RI; ERNEST ML; MIER J; OLEKSOWICZ L; ECKHARDT JR; LEVITT D; DOROSHOW JH
   CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY
   Clinical cancer research
   
   J.A. Sosman et al., "CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY", Clinical cancer research, 3(1), 1997, pp. 39-46
3. ISAACS RE; JENNIS A; ZAHOS K; CANTWELL S; ROSETI S; DORIA L; CORCORAN S; MURPHY L; WISNIEWSKI AM; MICHELIS MA; PECORA AL
   CYTOKINES FOR PRIMING AND MOBILIZATION OF PERIPHERAL-BLOOD PROGENITORCELLS (PBPC) IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY (HDC) WITHPERIPHERAL STEM-CELL TRANSPLANTATION (PSCT) - SEQUENTIAL ADMINISTRATION OF RHGM-CSF AND RHG-CSF VERSUS RHG-CSF ALONE
   Blood
   
   R.E. Isaacs et al., "CYTOKINES FOR PRIMING AND MOBILIZATION OF PERIPHERAL-BLOOD PROGENITORCELLS (PBPC) IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY (HDC) WITHPERIPHERAL STEM-CELL TRANSPLANTATION (PSCT) - SEQUENTIAL ADMINISTRATION OF RHGM-CSF AND RHG-CSF VERSUS RHG-CSF ALONE", Blood, 88(10), 1996, pp. 3669-3669
4. JENNIS A; PECORA AL; ISAACS RE; CANTWELL S; MICHELIS AM; ZAHOS K
   DOSE-INTENSIVE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND PLATINUM (DICEP) AS APRIMING MOBILIZATION REGIMEN FOR PERIPHERAL-BLOOD STEM-CELL (PBSC) HARVESTING PRIOR TO HIGH-DOSE CHEMOTHERAPY (HDC)/
   Blood
   
   A. Jennis et al., "DOSE-INTENSIVE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND PLATINUM (DICEP) AS APRIMING MOBILIZATION REGIMEN FOR PERIPHERAL-BLOOD STEM-CELL (PBSC) HARVESTING PRIOR TO HIGH-DOSE CHEMOTHERAPY (HDC)/", Blood, 88(10), 1996, pp. 1605-1605
5. PECORA AL; ZAHOS KM; JENNIS A; ISAACS RE; CANTWELL S; MICHELIS AM; GILLIO AP; BROCHSTEIN JA
   THE EXTENT AND TIMING OF EARLY (CD34-) HEMATOPOIETIC PROGENITOR MOBILIZATION FOLLOWING CHEMOTHERAPY AND(CD33)OR PRIMING/
   Blood
   
   A.L. Pecora et al., "THE EXTENT AND TIMING OF EARLY (CD34-) HEMATOPOIETIC PROGENITOR MOBILIZATION FOLLOWING CHEMOTHERAPY AND(CD33)OR PRIMING/", Blood, 88(10), 1996, pp. 2702-2702
6. LAZARUS HM; WINTON EF; WILLIAMS SF; GRINBLATT D; CAMPION M; COOPER BW; GUNN H; MANFREDA S; ISAACS RE
   PHASE-I MULTICENTER TRIAL OF INTERLEUKIN-6 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED BREAST-CANCER
   Bone marrow transplantation
   
   H.M. Lazarus et al., "PHASE-I MULTICENTER TRIAL OF INTERLEUKIN-6 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED BREAST-CANCER", Bone marrow transplantation, 15(6), 1995, pp. 935-942
7. ATKINS MB; KAPPLER K; MIER JW; ISAACS RE; BERKMAN EM
   INTERLEUKIN-6-ASSOCIATED ANEMIA - DETERMINATION OF THE UNDERLYING MECHANISM
   Blood
   
   M.B. Atkins et al., "INTERLEUKIN-6-ASSOCIATED ANEMIA - DETERMINATION OF THE UNDERLYING MECHANISM", Blood, 86(4), 1995, pp. 1288-1291
8. ZAHOS KM; BROCHSTEIN JA; ISAACS RE; JENNIS AA; MURAWSKI JA; PECORA AL
   TEMPERATURE MAINTENANCE OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) BY DRY ICE
   Blood
   
   K.M. Zahos et al., "TEMPERATURE MAINTENANCE OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) BY DRY ICE", Blood, 86(10), 1995, pp. 3962-3962
9. PECORA AL; BROCHSTEIN JA; JENNIS A; MICHELIS M; GRAZIOSO L; ZAHOS K; ISAACS RE
   TOTAL CD34- SUBSET PREDICT TIME TO NEUTROPHIL AND PLATELET ENGRAFTMENT AND HOSPITAL DISCHARGE IN PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDC) WITH PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC)( CELL CONTENT AND CD34+CD33)
   Blood
   
   A.L. Pecora et al., "TOTAL CD34- SUBSET PREDICT TIME TO NEUTROPHIL AND PLATELET ENGRAFTMENT AND HOSPITAL DISCHARGE IN PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDC) WITH PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC)( CELL CONTENT AND CD34+CD33)", Blood, 84(10), 1994, pp. 10000088-10000088
10. PARK JG; ISAACS RE; CHIEN P; SCHREIBER AD
    IN THE ABSENCE OF OTHER FC-RECEPTORS, FC-GAMMA-RIIIA TRANSMITS A PHAGOCYTIC SIGNAL THAT REQUIRES THE CYTOPLASMIC DOMAIN OF ITS GAMMA-SUBUNIT
    The Journal of clinical investigation
    
    J.G. Park et al., "IN THE ABSENCE OF OTHER FC-RECEPTORS, FC-GAMMA-RIIIA TRANSMITS A PHAGOCYTIC SIGNAL THAT REQUIRES THE CYTOPLASMIC DOMAIN OF ITS GAMMA-SUBUNIT", The Journal of clinical investigation, 92(4), 1993, pp. 1967-1973
11. LAZARUS HM; WINTON EF; WILLIAMS SF; GRINBLATT D; CAMPION M; MANFREDA S; COOPER BW; ISAACS RE
    PHASE-1 STUDY OF RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6, ESCHERICHIA-COLI) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) IN PATIENTS WITHPOOR-PROGNOSIS BREAST-CANCER
    Blood
    
    H.M. Lazarus et al., "PHASE-1 STUDY OF RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6, ESCHERICHIA-COLI) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) IN PATIENTS WITHPOOR-PROGNOSIS BREAST-CANCER", Blood, 82(10), 1993, pp. 10000173-10000173